589 related articles for article (PubMed ID: 17466429)
41. Effects of heroin and methadone on plasma cortisol and testosterone.
Mendelson JH; Meyer RE; Ellingboe J; Mirin SM; McDougle M
J Pharmacol Exp Ther; 1975 Nov; 195(2):296-302. PubMed ID: 1185598
[TBL] [Abstract][Full Text] [Related]
42. [Dutch research on the effectiveness of medical prescription of heroin; background, research design and preliminary results].
van den Brink W; Hendriks VM; Blanken P; van Ree JM
Ned Tijdschr Geneeskd; 2000 Jan; 144(3):108-12. PubMed ID: 10674115
[TBL] [Abstract][Full Text] [Related]
43. Temporal changes of smoking status and motivation among Chinese heroin-dependent, methadone-maintained smokers.
Li L; Liu Y; Zhang Y; Beveridge TJ; Zhou W
Addict Behav; 2010 Oct; 35(10):861-5. PubMed ID: 20542383
[TBL] [Abstract][Full Text] [Related]
44. Time-dependent neuroendocrine alterations and drug craving during the first month of abstinence in heroin addicts.
Shi J; Li SX; Zhang XL; Wang X; Le Foll B; Zhang XY; Kosten TR; Lu L
Am J Drug Alcohol Abuse; 2009; 35(5):267-72. PubMed ID: 19591065
[TBL] [Abstract][Full Text] [Related]
45. Depression in methadone maintenance treatment patients: rate and risk factors.
Peles E; Schreiber S; Naumovsky Y; Adelson M
J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
[TBL] [Abstract][Full Text] [Related]
46. Methadone dose and retention during treatment of heroin addicts with Axis I psychiatric comorbidity.
Maremmani I; Zolesi O; Aglietti M; Marini G; Tagliamonte A; Shinderman M; Maxwell S
J Addict Dis; 2000; 19(2):29-41. PubMed ID: 10809518
[TBL] [Abstract][Full Text] [Related]
47. Changes in the hypothalamic-pituitary-adrenal axis and leptin levels during antidepressant treatment.
Himmerich H; Zimmermann P; Ising M; Kloiber S; Lucae S; Kunzel HE; Binder EB; Holsboer F; Uhr M
Neuropsychobiology; 2007; 55(1):28-35. PubMed ID: 17556850
[TBL] [Abstract][Full Text] [Related]
48. Erectile dysfunction among male heroin addicts receiving methadone maintenance treatment in Guangdong, China.
Chen W; Li X; Li X; Ling L; Xia Y; Chen J; He Q
J Addict Med; 2012 Sep; 6(3):212-8. PubMed ID: 22614937
[TBL] [Abstract][Full Text] [Related]
49. Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program.
Maremmani I; Pani PP; Mellini A; Pacini M; Marini G; Lovrecic M; Perugi G; Shinderman M
J Addict Dis; 2007; 26(1):61-70. PubMed ID: 17439869
[TBL] [Abstract][Full Text] [Related]
50. Dysregulation of the hypothalamic-pituitary-adrenal axis in postpartum depression.
Jolley SN; Elmore S; Barnard KE; Carr DB
Biol Res Nurs; 2007 Jan; 8(3):210-22. PubMed ID: 17172320
[TBL] [Abstract][Full Text] [Related]
51. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
Maremmani I; Pani PP; Pacini M; Perugi G
J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494
[TBL] [Abstract][Full Text] [Related]
52. Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands.
Blanken P; Hendriks VM; van Ree JM; van den Brink W
Addiction; 2010 Feb; 105(2):300-8. PubMed ID: 19922517
[TBL] [Abstract][Full Text] [Related]
53. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
[TBL] [Abstract][Full Text] [Related]
54. Repeat doses of antenatal steroids and hypothalamic-pituitary-adrenal axis (HPA) function.
Battin MR; Bevan C; Harding JE
Am J Obstet Gynecol; 2007 Jul; 197(1):40.e1-6. PubMed ID: 17618750
[TBL] [Abstract][Full Text] [Related]
55. Cerebral phosphorus metabolite and transverse relaxation time abnormalities in heroin-dependent subjects at onset of methadone maintenance treatment.
Silveri MM; Pollack MH; Diaz CI; Nassar LE; Mendelson JH; Yurgelun-Todd DA; Renshaw PF; Kaufman MJ
Psychiatry Res; 2004 Sep; 131(3):217-26. PubMed ID: 15465291
[TBL] [Abstract][Full Text] [Related]
56. Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients.
Ronchi CL; Ferrante E; Rizzo E; Giavoli C; Verrua E; Bergamaschi S; Lania AG; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2008 Oct; 69(4):608-12. PubMed ID: 18410544
[TBL] [Abstract][Full Text] [Related]
57. Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India.
Chittiprol S; Kumar AM; Satishchandra P; Taranath Shetty K; Bhimasena Rao RS; Subbakrishna DK; Philip M; Satish KS; Ravi Kumar H; Kumar M
Psychoneuroendocrinology; 2008 Jan; 33(1):30-40. PubMed ID: 17993249
[TBL] [Abstract][Full Text] [Related]
58. Hypothalamic-pituitary-adrenal axis in methadone-treated heroin addicts.
Cushman P; Bordier B; Hilton JG
J Clin Endocrinol Metab; 1970 Jan; 30(1):24-9. PubMed ID: 4902202
[No Abstract] [Full Text] [Related]
59. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
[TBL] [Abstract][Full Text] [Related]
60. Pain perception of intravenous heroin users on maintenance therapy with levomethadone.
Schall U; Katta T; Pries E; Klöppel A; Gastpar M
Pharmacopsychiatry; 1996 Sep; 29(5):176-9. PubMed ID: 8895942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
